Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Antibiotics May Not Be Needed Following Abscess Incision and Drainage

By HospiMedica International staff writers
Posted on 19 Apr 2010
Antibiotics do not improve outcomes after incision and drainage of uncomplicated skin abscesses, but may perhaps prevent new abscesses at one month, according to a new study.

Researchers at Washington Hospital Center (DC, USA) and Wilford Hall Medical Center (Lackland Air Force Base, TX, USAl) conducted a multicenter trial that randomized 212 adults to receive either trimethoprim-sulfamethoxazole (TS, 160 mg/800 mg) or placebo after incision and drainage of community-acquired abscesses. More...
The researchers assessed treatment failure using clinical follow-up, telephone follow-up, and medical record review, recording the development of new lesions within 30 days. All bacterial isolates tested were uniformly sensitive to TS; thus, the primary outcome was treatment failure at 7 days (defined as no improvement after 2 days), development of a new separate abscess within 7 days, or worsening infection within 7 days requiring intervention. In all, 88 patients in the antibiotic group and 102 in the placebo group completed 7 days of follow-up; of these, 46 and 50, respectively, returned at 30 days.

The researchers found that there was no significant difference in treatment failure rates at 7 days (17% in the antibiotic group and 26% in the placebo group). A statistically similar incidence of treatment failure was observed in patients receiving TS compared to placebo. On 30-day follow-up (successful in 69% of the patients), the researchers observed significantly fewer new lesions in the antibiotic (9%) versus the placebo (28%) group. The study was published early online on March 29, 2010, in the Annals of Emergency Medicine.

"Antibiotics don't help with resolution of infection,” said lead author Gillian R. Schmitz., M.D. "The most important thing is to open the wound, clean it, and get the pus out; more study needs to be done to draw a conclusion about recurrence, because we lost so many to follow-up at 30 days.”

Pus consists of a thin, protein-rich fluid, known as liquor puris, and dead cells, which are part of the body's immune response. When neutrophils are needed to fight infection, they move to the site of infection by a process known as chemotaxis, usually triggered by cytokines released from macrophages that sense invading organisms. At the site of infection, the neutrophils engulf and kill bacteria. Eventually, the neutrophils die, and are then phagocytosed by macrophages, which break them down further. Pus is the viscous material composed of these dead neutrophils.

Related Links:
Washington Hospital Center
Wilford Hall Medical Center


Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
X-Ray Generator
Advantage Plus Generators
New
Patient Preoperative Skin Preparation
BD ChloraPrep
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Health IT

view channel
Photo courtesy of Adobe Stock

Automated System Classifies and Tracks Cardiogenic Shock Across Hospital Settings

Cardiogenic shock remains a difficult, time-sensitive emergency, with delayed identification driving poor outcomes and persistently high mortality. Many cases go undocumented even at advanced stages, hindering... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.